Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124297374 | 12429737 | 4 | F | 20160417 | 20160718 | 20160602 | 20160729 | EXP | ES-CELGENEUS-ESP-2016047587 | CELGENE | 75.17 | YR | M | Y | 0.00000 | 20160729 | OT | ES | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124297374 | 12429737 | 1 | PS | ABRAXANE | PACLITAXEL | 1 | Intravenous drip | Y | U | 21660 | 125 | MG/M**2 | INJECTION FOR INFUSION | ||||||
| 124297374 | 12429737 | 2 | SS | ABRAXANE | PACLITAXEL | 1 | Intravenous drip | Y | U | 21660 | 125 | MG/M**2 | INJECTION FOR INFUSION | ||||||
| 124297374 | 12429737 | 3 | SS | ABRAXANE | PACLITAXEL | 1 | Intravenous drip | Y | U | 21660 | 125 | MG/M**2 | INJECTION FOR INFUSION | ||||||
| 124297374 | 12429737 | 4 | SS | ABRAXANE | PACLITAXEL | 1 | Intravenous drip | Y | U | 21660 | 75 | MG/M**2 | INJECTION FOR INFUSION | ||||||
| 124297374 | 12429737 | 5 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous drip | Y | U | 55974 | 1000 | MG/M**2 | INJECTION FOR INFUSION | ||||||
| 124297374 | 12429737 | 6 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous drip | Y | U | 55974 | 1000 | MG/M**2 | INJECTION FOR INFUSION | ||||||
| 124297374 | 12429737 | 7 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous drip | Y | U | 55974 | 1000 | MG/M**2 | INJECTION FOR INFUSION | ||||||
| 124297374 | 12429737 | 8 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous drip | Y | U | 55974 | 600 | MG/M**2 | INJECTION FOR INFUSION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124297374 | 12429737 | 1 | Adenocarcinoma pancreas |
| 124297374 | 12429737 | 5 | Adenocarcinoma pancreas |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124297374 | 12429737 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124297374 | 12429737 | Anaemia | |
| 124297374 | 12429737 | Gastrointestinal haemorrhage | |
| 124297374 | 12429737 | Neutropenia | |
| 124297374 | 12429737 | Platelet count decreased | |
| 124297374 | 12429737 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124297374 | 12429737 | 1 | 20160407 | 20160414 | 0 | |
| 124297374 | 12429737 | 2 | 20160511 | 20160524 | 0 | |
| 124297374 | 12429737 | 3 | 20160601 | 20160613 | 0 | |
| 124297374 | 12429737 | 4 | 20160623 | 0 | ||
| 124297374 | 12429737 | 5 | 20160407 | 20160414 | 0 | |
| 124297374 | 12429737 | 6 | 20160511 | 20160524 | 0 | |
| 124297374 | 12429737 | 7 | 20160601 | 20160613 | 0 | |
| 124297374 | 12429737 | 8 | 20160623 | 0 |